So basically, if you have a diabetic patient with high ischemic risk, long term monotherapy with Plavix, after standard dual antiplatelet therapy, may provide lower ischemic events compared with aspirin only with similar bleeding rates.
I have observed this in practice too.
Congratulations to JACC Interv on great paper
👇
Clopidogrel vs Aspirin According to Diabetes Mellitus: A Prespecified Analysis of the SMART-CHOICE 3 Trial:
@JACCJournals
🥸 Plavix only as monotherapy in patients with DM: SMART-CHOICE 3
😱 Nice paper in JACC Interv
👇👇👇👇